va glp 1 coverage GLP-1 for obesity treatment in 13 US states' Medicaid programs The evolving landscape of anti-obesity
Description
PAH is a rare condition that can occur 25 months after CoolSculpting, where the treated area develops a hardened, enlarged bulge of fat instead of reducing
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
About the authors Dr Atreyi Chakrabarty is a business analyst at Lifescience Dynamics, specialising in pharmaceutical insights and strategy across neurology, womens health, oncology, and rare diseases
These efforts aim to establish novel roles for GLP-1RAs in cancer prevention
Med Res Arch
Whats not to love
